(FM) Oftalmología

2016

1. Cambios en el dispositivo de drenaje de Ahmed: ¿mejora su eficacia hipotensora?

   Archivos de la Sociedad Española de Oftalmologia, Vol. 91, Núm. 9, pp. 407-408

2. Dietary marine ω-3 fatty acids and incident sight-threatening retinopathy in middle-aged and older individuals with type 2 diabetes: Prospective investigation from the PREDIMED trial

   JAMA Ophthalmology, Vol. 134, Núm. 10, pp. 1142-1149

3. El grupo de tutores y docentes de residentes de oftalmología

   Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears, Vol. 24, Núm. 3

4. Evaluation of 10 AMD Associated polymorphisms as a cause of choroidal neovascularization in highly myopic eyes

   PLoS ONE, Vol. 11, Núm. 9

5. Evaluation of the retinal nerve fiber layer thickness, the mean deviation, and the visual field index in progressive glaucoma

   Journal of Glaucoma, Vol. 25, Núm. 3, pp. e229-e235

6. Molecular basis of factor H R1210C association with ocular and renal diseases

   Journal of the American Society of Nephrology, Vol. 27, Núm. 5, pp. 1305-1311

7. Omega-3 Fatty Acids and Age-Related Macular Degeneration

   Ophthalmic Research, Vol. 55, Núm. 2, pp. 62-69

8. Optical Coherence Tomography Assessment before and after Vitamin Supplementation in a Patient with Vitamin A Deficiency

   Medicine (United States), Vol. 95, Núm. 6

9. Patient considerations in cataract surgery - The role of combined therapy using phenylephrine and ketorolac

   Patient Preference and Adherence, Vol. 10, pp. 1795-1801

10. Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease

    Investigative Ophthalmology and Visual Science, Vol. 57, Núm. 14, pp. 6447-6454

11. Single- and repeated-dose toxicity study of bevacizumab, ranibizumab, and aflibercept in ARPE-19 cells under normal and oxidative stress conditions

    Biochemical Pharmacology, Vol. 103, pp. 129-139